Roundup Manufacturer Settles Cancer Suits for $10 Billion

BayerAG, the chemical and pharmaceutical conglomerate, has agreed to pay $10 billion to settle a series of lawsuits brought against it over its signature weed killer, Roundup. The herbicide became the subject of major public controversy after it was discovered that Roundup had carcinogenic properties, a fact that was known by its manufacturer, Monsanto, for decades. The company covered up this fact and continued to sell Roundup to the public, netting billions of dollars from sales of the weed killer in the interim.… Read the rest

Heart Surgery Drug Trasylol Withdrawn from Market

The German pharmaceutical company, Bayer AG, announced that it will withdraw Trasylol, its controversial drug used for heart surgery, from the market. The withdrawal was due in part to a study performed in Canada which suggested that Trasylol increased rates of death.

The New England Journal of Medicine published the results of a study it conducted finding that Trasylol increased the risks of stroke, heart attack, kidney failure, and death. The research concluded that stopping the use of Trasylol would result in the prevention of 10,000 to 11,000 cases of kidney failure per year along with the savings of over … Read the rest